Atlas Trials

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Clinical trial NCT02375620 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02375620
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Short Stature Children Born Small for Gestational Age (SGA)
Start date
2015-04-23
Primary completion
2023-12-12
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.